Search

Your search keyword '"Enbrel (Medication) -- Evaluation"' showing total 4 results
Start Over Descriptor "Enbrel (Medication) -- Evaluation" Publisher cq-roll call, inc.
4 results on '"Enbrel (Medication) -- Evaluation"'

1. Event Brief of Q1 2014 Amgen Earnings Conference Call - Final

Subjects
Amgen Inc., Barclays Capital Inc., Investment banks -- Evaluation, Biotechnology industry, Business, Enbrel (Medication) -- Evaluation, Neupogen (Medication) -- Evaluation
Abstract

CORPORATE PARTICIPANTS . Arvind Sood - Amgen Inc.,VP of IR . Bob Bradway - Amgen Inc.,Chairman & CEO . Michael Kelly - Amgen Inc.,Interim CFO . Tony Hooper - Amgen [...]

Published
2014

2. Q2 2008 Amgen Earnings Conference Call - Final

Subjects
Amgen Inc., Pharmaceutical industry, Business, Aranesp (Medication) -- Evaluation, Enbrel (Medication) -- Evaluation
Abstract

Original Source: FD (FAIR DISCLOSURE) WIRE OPERATOR: My name is Dennis, and I will be your conference facilitator today for Amgen's second quarter 2008 financial results conference call. All lines [...]

Published
2008

3. Event Brief of Q1 2007 Wyeth Earnings Conference Call - Final

Subjects
Pharmaceutical industry, Business, Enbrel (Medication) -- Evaluation, Prevnar (Vaccine) -- Evaluation
Abstract

Original Source: FD (FAIR DISCLOSURE) WIRE PARTICIPANTS . Bob Essner, Wyeth, Chairman, CEO . Ken Martin, Wyeth, CFO, Vice Chairman . Bernard Poussot, Wyeth, President, Vice Chairman . Joe Mahady, [...]

Published
2007

4. Event Brief of Q1 2007 Wyeth Earnings Conference Call - Final

Subjects
The Goldman Sachs Group Inc., Investment banks -- Evaluation, Pharmaceutical industry, Business, Enbrel (Medication) -- Evaluation, Prevnar (Vaccine) -- Evaluation
Abstract

Original Source: FD (FAIR DISCLOSURE) WIRE PARTICIPANTS . Robert Essner, Wyeth, Chairman, CEO . Ken Martin, Wyeth, CFO, Vice Chairman . Bernard Poussot, Wyeth, President, Vice Chairman . Joe Mahady, [...]

Published
2007

Catalog

Books, media, physical & digital resources
See catalog results